SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001274644-16-000092
Filing Date
2016-01-19
Accepted
2016-01-19 08:14:06
Documents
1
Period of Report
2016-01-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_145320923545023.html 4  
1 FORM 4 wf-form4_145320923545023.xml 4 3596
  Complete submission text file 0001274644-16-000092.txt   5093
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PANORAMA CAPITAL 2440 SAND HILL ROAD, SUITE 302 MENLO PARK CA 94025
Business Address
Aggarwal Gaurav (Reporting) CIK: 0001551965 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 161347021